Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining...

Area of Science:

• Neuroimmunology
• Stem Cell Biology
• Immunology

Background:

• Systemic injection of neural stem/precursor cells (NPCs) ameliorates experimental autoimmune encephalomyelitis (EAE).
• NPCs exert therapeutic effects through neuroprotection and immune modulation.
• Mechanisms underlying NPC therapeutic plasticity require further elucidation.

Purpose of the Study:

• To identify a specific factor mediating the immune modulatory capacity of transplanted NPCs.
• To understand how NPCs influence immune cell behavior in vivo.
• To investigate the role of stem cell regulators in NPC-mediated therapy.

Main Methods:

• Subcutaneous injection of NPCs into SJL mice with PLP-induced EAE prior to disease onset.
• Tracking of exogenous NPCs in draining lymph nodes and other organs.
• Analysis of stem cell regulators (BMP-4, Noggin, Sonic hedgehog) in lymph nodes.
• Assessment of myeloid dendritic cell (DC) activation and T cell expansion ex vivo and in vitro.

Main Results:

• NPC treatment significantly improved clinical EAE scores compared to controls.
• Injected NPCs localized to draining lymph nodes and interacted with immune cells.
• NPCs were not found in the brain or spinal cord.
• Upregulation of BMP-4, Noggin, and Sonic hedgehog observed in draining lymph nodes.
• NPCs inhibited DC maturation and restrained encephalitogenic T cell expansion.
• A novel BMP-4-dependent mechanism hindering DC maturation was identified.

Conclusions:

• The study identifies a TGF-beta/BMP family member (BMP-4) as a novel tolerogenic factor released by NPCs.
• This BMP-4 pathway represents a potential therapeutic target for autoimmune diseases.
• Further research is ongoing to utilize this pathway for vaccination therapy in autoimmune conditions.